𝑭𝒐𝒓𝒈𝒆𝒕 𝑭𝒍𝒂𝒔𝒉𝒚 𝑪𝒂𝒓𝒔 𝒂𝒏𝒅 𝒀𝒂𝒄𝒉𝒕𝒔 – A Clean Bill of Health Is the Ultimate Status Symbol

An IMGlobalWealth.com News Report

In 2026, wealth is being recalibrated. For high-net-worth individuals (HNWIs), the traditional markers of success, property portfolios, private jets and diversified asset allocations, are increasingly accompanied by a more fundamental metric: health. Longevity, vitality and performance are no longer lifestyle aspirations; they are becoming central pillars of wealth strategy.

“As the boundaries between wealth management and wellbeing strategy blur, the definition of prosperity is evolving. The ultimate benchmark of success may no longer be the size of one’s portfolio, but the durability of one’s health”

Article Highlights

• Health is emerging as a defining benchmark of modern wealth.
• Equinox’s $40,000-per-year Optimize programme has reportedly attracted over 1,000 applicants.
• The global wellness economy is valued at more than $5 trillion.
• Longevity and wellbeing are rising spending priorities among affluent clients.
• Wealth management is expanding to incorporate health as strategic capital.

A striking example of this shift is the launch of Optimize, a $40,000-per-year personalised health optimisation programme by Equinox. Founded in New York in 1991, Equinox has grown into a global luxury fitness and lifestyle brand operating more than 300 high-end clubs across major cities. Long positioned at the intersection of performance, design and affluence, the company’s latest offering moves decisively into the longevity space. The programme integrates advanced biometric testing, personal training, nutrition planning, sleep coaching and recovery therapies under a concierge model. Reports of a waiting list exceeding 1,000 applicants suggest strong appetite among affluent consumers for structured, data-driven health optimisation.

This demand is not anecdotal. The Global Wellness Institute estimates the global wellness economy to be worth more than $5 trillion, spanning preventative health, fitness, mental wellbeing, nutrition and personalised medicine.

Meanwhile, private banking surveys, including those by Julius Baer, the Zurich-headquartered Swiss private banking group founded in 1890 and widely regarded as one of the world’s leading pure-play wealth managers, indicate that longevity and wellbeing now rank among the top spending priorities for affluent clients, often outpacing traditional status goods.

Julius Baer serves high- and ultra-high-net-worth individuals across Europe, Asia, the Middle East and Latin America, advising entrepreneurial families, business owners and global investors with substantial cross-border assets. Its annual Global Wealth and Lifestyle Report has become an industry benchmark for tracking spending patterns and lifestyle priorities among the global wealthy.

Demographics reinforce the trend. Populations in advanced economies are ageing, yet remaining economically active for longer. Affluent individuals in their 50s, 60s and beyond increasingly view healthspan, the number of years lived in good health, as a measurable return on capital. In this context, investments in advanced diagnostics, regenerative medicine, performance training and longevity research are seen less as discretionary expenditure and more as strategic risk mitigation.

For wealth managers, the implications are structural. Advisory conversations are expanding beyond asset preservation and intergenerational transfer to include quality-of-life preservation. Portfolios are beginning to reflect exposure to healthtech, biotech and preventative healthcare sectors. Equally, advisors are recognising that client engagement increasingly involves broader lifestyle capital – time, vitality and resilience.

In effect, health is being repositioned as an asset class in its own right. A strong balance sheet may secure financial freedom; a strong cardiovascular system may secure the capacity to enjoy it. As the boundaries between wealth management and wellbeing strategy blur, the definition of prosperity is evolving. The ultimate benchmark of success may no longer be the size of one’s portfolio, but the durability of one’s health.